using Pradaxa (dabigatran) for more than atrial fibrillation

We're getting questions about using Pradaxa (dabigatran) for more than atrial fibrillation.

There's some evidence for other indications...but these aren't FDA approved and there are other limitations.

Treating venous thromboembolism. Pradaxa 150 mg BID for 6 months seems to work as well as warfarin to treat acute deep venous thrombosis or pulmonary embolism...and has a similar bleeding risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote